CCND1 and type 2 diabetes mellitus: The network predicted that quercetin, luteolin, kaempferol, and phaseoloidin might be potential ingredients in GP and that PTGS2, AKT, MAPK1, TNF, INSR, IL6, MAPK8, PRKCB, NOS3, iNS, PIK3CG, BCL2, VEGFA, EGFR, CCND1, CASP3, and FOS might be potential targets of T2DM.